source
- Biogen CEO says early-stage R&D now a priority after record five INDs this yearBiogen's chief executive Chris Viehbacher told analysts that the company has shifted its strategy toward early-stage research and development. He highlighted that Biogen has filed five investigati…
- Epic's data‑blocking tactics curb health‑tech innovation, investigation findsA STAT investigation reveals that Epic Systems, the leading electronic health record vendor, is deliberately limiting access to patient data for competing software developers. This practice gives E…